Back to search

Article

Robust clinical detection of SARS-CoV-2 variants by RT-PCR/MALDI-TOF multi-target approach

2021-09-16

Abstract excerpt

The COVID-19 pandemic sparked rapid development of SARS-CoV-2 diagnostics. However, emerging variants pose the risk for target dropout and false-negative results secondary to primer/probe binding site (PBS) mismatches. The Agena MassARRAY ® SARS-CoV-2 Panel combines RT-PCR and MALDI-TOF mass-spectrometry to probe for five targets across N and ORF1ab genes, which provides a robust platform to accommodate PBS mismat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
faaaf3a7-ef18-502c-8880-6cecbd08c015
DOI
10.1101/2021.09.09.21263348
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Robust clinical detection of SARS-CoV-2 variants by RT-PCR/MALDI-TOF multi-target approachDOI 10.1101/2021.09.09.21263348
Select a neighboring publication to make it the new centre.